These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22593995)

  • 1. Response of malignant breast tumours to neoadjuvant chemotherapy evaluated with Tc-99m MIBI.
    Listewnik MH; Birkenfeld B; Foszczyńska-Kłoda M; Listewnik MJ; Piwowarska-Bilska H; Zorga P
    Ann Acad Med Stetin; 2011; 57(1):73-8. PubMed ID: 22593995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
    J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
    Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
    Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
    Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N
    J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].
    Liu ZZ; Lu ZD; Zhang HW; Yang H; Liu H; Li LF; Li WL; Cui SD
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):544-6. PubMed ID: 22093636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography.
    Mankoff DA; Dunnwald LK; Gralow JR; Ellis GK; Drucker MJ; Livingston RB
    Cancer; 1999 Jun; 85(11):2410-23. PubMed ID: 10357412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
    Marshall C; Eremin J; El-Sheemy M; Eremin O; Griffiths PA
    Nucl Med Commun; 2005 Jan; 26(1):9-15. PubMed ID: 15604942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m methoxyisobutylisonitrile scintimammography for monitoring and early prediction of breast cancer response to neoadjuvant chemotherapy.
    Novikov SN; Kanaev SV; Petr KV; Tatyana SY; Elena TA; Ludmila JA; Nikolay ID; Zhanna BV; Pavel KI
    Nucl Med Commun; 2015 Aug; 36(8):795-801. PubMed ID: 26011586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
    Ciarmiello A; Del Vecchio S; Silvestro P; Potena MI; Carriero MV; Thomas R; Botti G; D'Aiuto G; Salvatore M
    J Clin Oncol; 1998 May; 16(5):1677-83. PubMed ID: 9586878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
    Tiling R; Kessler M; Untch M; Sommer H; Linke R; Brinkbäumer K; Hahn K
    Onkologie; 2003 Feb; 26(1):27-31. PubMed ID: 12624514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predicative value of 99mTc-MIBI scintimammography in neoadjuvant chemotherapeutic effect of patients with operable breast cancer].
    Liu ZZ; Lu ZD; Liu H; Li LF; Zhang HW; Yang H; Li WL; Cui SD
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):382-4. PubMed ID: 21418909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
    Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
    Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
    Dunnwald LK; Gralow JR; Ellis GK; Livingston RB; Linden HM; Lawton TJ; Barlow WE; Schubert EK; Mankoff DA
    Cancer; 2005 Feb; 103(4):680-8. PubMed ID: 15637688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
    Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
    Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
    Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
    Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
    Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
    Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
    Guo C; Zhang C; Liu J; Tong L; Huang G
    Nucl Med Commun; 2016 Jul; 37(7):675-88. PubMed ID: 26974314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
    Collarino A; de Koster EJ; Valdés Olmos RA; de Geus-Oei LF; Pereira Arias-Bouda LM
    Clin Breast Cancer; 2018 Feb; 18(1):9-18. PubMed ID: 28728876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer.
    Chen J; Wu H; Zhou J; Hu J
    Chin Med J (Engl); 2003 Apr; 116(4):620-4. PubMed ID: 12875735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.